New research from the UVA Department of Surgery’s Tsung Research Group, published in JAMA Network Open and selected as an Editor’s Pick, provides a national evaluation of real-world use of histotripsy for liver tumors.
On August 4, 2026, the UVA Paul and Diane Manning Institute of Biotechnology hosted its inaugural SPARK Tank competition, bringing together a dynamic mix of faculty, including from the School of […]
When people think about infectious disease outbreaks, it’s easy to focus on the pathogen itself. But according to researchers at the University of Virginia’s Biocomplexity Institute, understanding how diseases spread often has less to do with biology alone and more to do with the complex networks of people, places, and behaviors through which they move.
In this episode of Good Disruption, UVA Professor Jack Van Horn joins hosts Yael Grushka-Cockayne and Mike Lenox to explore brain-computer interfaces, a rapidly advancing neurotechnology that translates brain signals into action. From restoring movement and communication to bypassing damaged neural pathways, BCIs hold remarkable promise — alongside significant challenges — as the field moves from science fiction to reality.
Environmental scientists tested for toxic metals and pollutants in seven areas across the eastern U.S.
A new study published in Nature, co-authored by UVA doctoral student Thomas Storrs, provides the first national analysis of racial disparities in early federal mortgage lending. Examining over 100,000 records across 38 states, researchers found that from 1935 to 1947, Black Americans received just 2% of FHA loans and 5% of VA home loans despite comprising roughly 10% of the U.S. population and veteran population.
GET THE STORIES BEHIND THE RESEARCH
Receive updates about the discoveries, researchers, and ideas shaping our world — straight from UVA.
Temporary anxiety can often surface before the first day of school. Sometimes, that can help kids get in the right mindset for a big day. But when anxiety becomes a constant feature of children’s and teenagers’ days, that stress doesn’t switch off when they leave the classroom or finish an exam. It can become the body’s normal, staying with learners long after graduation.
Modeled after the reality show where entrepreneurs pitch investors, some of UVA’s top researchers are seeking funding for life-changing medical breakthroughs.
The bacterium that causes tuberculosis is shielded by a protective outer membrane that makes the disease difficult to treat. UVA researchers helped identify chemical features that allow drugs to breach that defense.
Qnovia, Inc., a clinical-stage pharmaceutical company, today announced it has secured a worldwide exclusive license to an innovative antimicrobial peptide from the University of Virginia Licensing & Ventures Group. The license marks Qnovia’s expansion into a second major therapeutic area, complementing its lead smoking cessation program as the company pursues breakthrough solutions to population-scale health challenges.
UVA Health researchers have found that gliomas, the most common primary brain tumors in adults, may be more receptive to focused ultrasound drug delivery than normal brain tissue.
A UVA neurologist explains what global transient amnesia is, and what remains a mystery.